MyMetabolon Login
© 2020 Metabolon, Inc. All rights reserved.
Metabolon Metabolon
  • Metabolomics
    • About Metabolomics
    • Our Process
    • Technology & Knowledgebase
    • Setting the Standard: The 4Cs
    • Our Latest Insights
  • Solutions
    • Column 1
      • Products & Services
        • Global Metabolomics
        • Lipidomics
        • Targeted Assays
        • Study Design & Consulting
        • Sample Preparation & Handling
        • Study Success Sample Handling Kit
        • Reporting & Interpretation
        • Bioinformatics
        • MyMetabolon Client Portal
    • Column 2
      • By Research & Development Phase
        • Discovery & Target Selection
        • Lead Candidate Selection
        • Preclinical
        • Clinical Development
        • Manufacturing & Bioprocessing
    • Column 3
      • By Therapeutic Area
        • Cardiovascular Disease
        • COVID-19
        • Diabetes
        • Gastrointestinal
        • Liver Disease
        • Microbiome
        • Neuroscience
        • Oncology
        • Renal & Urological Disorders
        • Respiratory Disorders
    • Column 4
      • By Sector
        • Academic
        • Agriculture
        • Biotech / Pharmaceutical
        • Precision Medicine
        • Nutrition
        • Personal Care & Cosmetics
        • Population Health
        • Veterinary & Animal Health
  • Insights
    • Our Latest Insights
    • Blog
    • News & Events
  • Resources
    • Resource Library
    • Client Stories
    • COVID-19
  • Company
    • About Us
    • Working With Us (FAQ)
    • Leadership
    • Careers
    • Strategic Partnering
    • News & Events
    • Contact Us
MyMetabolon
Demo Our Data
Metabolon
Demo Our Data

Company News & Press

Leveraging Machine Learning to Advance Precision Medicine
23 November 2020

Leveraging Machine Learning to Advance Precision Medicine

GEN Genetic Engineering & Biotechnology News - Metabolon says that its Precision Metabolomics™ platform can improve quality control, data curation, and knowledge building. According to William LeFew, PhD, Metabolon’s director of data science, the company uses machine learning to automate routine tasks and teachable processes so its scientists can focus their efforts on the challenges that most require their expertise.
Clinical OMICs: ’Omics in Translation
17 June 2020

Clinical OMICs: ’Omics in Translation

“One of the unique characteristics of metabolomics is its ability to reveal functionality. This is of great benefit as it can help to fill the gaps of other ’omics where insights may be lacking. Scientists can use metabolomics to provide a bridge with other ’omic approaches to more completely understand disease manifestation and state of the phenotype in the present time.” - Annie Evans, Director of R&D at Metabolon.
North Carolina Biotechnology Center: Metabolon Study to Provide Better Understanding of COVID-19
23 April 2020

North Carolina Biotechnology Center: Metabolon Study to Provide Better Understanding of COVID-19

Why do some patients die from the COVID-19 coronavirus, while others have symptoms so mild they may not even realize they’re sick? How can treatments for the disease work in some cases, while having no positive effect in others?
GEN Bioprocessing: Optimizing Yield and Improving Overall Culture Performance with Metabolomics
1 April 2020

GEN Bioprocessing: Optimizing Yield and Improving Overall Culture Performance with Metabolomics

GEN Bioprocessing April 2020 – Metabolomics can elevate bioprocessing through analysis of metabolite data streams. These same streams are critical to the Bioprocess 4.0 approach.
Biotechniques: Talking Techniques | Microbiome studies; big data analysis, LCMS and at-home fecal sample collection
1 April 2020

Biotechniques: Talking Techniques | Microbiome studies; big data analysis, LCMS and at-home fecal sample collection

In this episode BioTechniques Digital Editor, Tristan Free speaks to Annie Evans, Director of R&D and David Foster, Vice President of Data and Informatics at Metabolon (NC, USA) about the latest developments in microbiome studies, including big data analysis, LCMS, alpha diversity and at-home fecal sample collection.
BioTechniques: Talking Techniues | Greg Michelotti on metabolomics, precision medicine and frailty biomarkers
2 August 2019

BioTechniques: Talking Techniues | Greg Michelotti on metabolomics, precision medicine and frailty biomarkers

BioTechniques Digital Editors Abigail Sawyer and Tristan Free talk to Greg Michelotti of Metabolon (NC, USA) about metabolomics, its potential applications in precision medicine and the new $4 million research collaboration with the Canadian Longitudinal Study of Aging (CLSA) and other Canadian research groups to identify biomarkers for frailty.
WRAL TechWire: Morrisville-based Metabolon mines data for causes of frailty in the elderly
31 July 2019

WRAL TechWire: Morrisville-based Metabolon mines data for causes of frailty in the elderly

Metabolon, a Morrisville-based precision health company specializing in a technology called metabolomics, is teaming with three Canadian research groups to discover humans’ frailty biomarkers, determine the severity of frailty and what can be done to help avoid the condition.
North Carolina Biotechnology Center: Metabolon Mines Data for Causes of Frailty in the Elderly
29 July 2019

North Carolina Biotechnology Center: Metabolon Mines Data for Causes of Frailty in the Elderly

Some people age with relative ease, while others become medically frail. They lose strength, fatigue more easily, or their health, social and psychological challenges accumulate, and they must depend on others for assistance with activities of daily living.
Health Research Innovation Portal: Partnership created to uncover reasons for frailty in aging populations
10 July 2019

Health Research Innovation Portal: Partnership created to uncover reasons for frailty in aging populations

Three national research groups and a leading biotechnology company are teaming together to discover the frailty biomarkers that may shed light on why some people become frail, determine the severity of frailty and what can be done to help avoid the condition.
Biospace: Partnership created to uncover reasons for frailty in aging populations
10 July 2019

Biospace: Partnership created to uncover reasons for frailty in aging populations

To date there has been little consensus on the biological mechanisms underpinning frailty. Analysis of the CLSA samples will allow researchers to identify metabolites that will help to improve not only early prediction of frailty, but also lead to further research on treatments addressing specific aspects of frailty.

Find Us at These Events

Leveraging Machine Learning to Advance Precision Medicine
23 November 2020

Leveraging Machine Learning to Advance Precision Medicine

GEN Genetic Engineering & Biotechnology News - Metabolon says that its Precision Metabolomics™ platform can improve quality control, data curation, and knowledge building. According to William LeFew, PhD, Metabolon’s director of data science, the company uses machine learning to automate routine tasks and teachable processes so its scientists can focus their efforts on the challenges that most require their expertise.
Clinical OMICs: ’Omics in Translation
17 June 2020

Clinical OMICs: ’Omics in Translation

“One of the unique characteristics of metabolomics is its ability to reveal functionality. This is of great benefit as it can help to fill the gaps of other ’omics where insights may be lacking. Scientists can use metabolomics to provide a bridge with other ’omic approaches to more completely understand disease manifestation and state of the phenotype in the present time.” - Annie Evans, Director of R&D at Metabolon.
North Carolina Biotechnology Center: Metabolon Study to Provide Better Understanding of COVID-19
23 April 2020

North Carolina Biotechnology Center: Metabolon Study to Provide Better Understanding of COVID-19

Why do some patients die from the COVID-19 coronavirus, while others have symptoms so mild they may not even realize they’re sick? How can treatments for the disease work in some cases, while having no positive effect in others?
GEN Bioprocessing: Optimizing Yield and Improving Overall Culture Performance with Metabolomics
1 April 2020

GEN Bioprocessing: Optimizing Yield and Improving Overall Culture Performance with Metabolomics

GEN Bioprocessing April 2020 – Metabolomics can elevate bioprocessing through analysis of metabolite data streams. These same streams are critical to the Bioprocess 4.0 approach.
Biotechniques: Talking Techniques | Microbiome studies; big data analysis, LCMS and at-home fecal sample collection
1 April 2020

Biotechniques: Talking Techniques | Microbiome studies; big data analysis, LCMS and at-home fecal sample collection

In this episode BioTechniques Digital Editor, Tristan Free speaks to Annie Evans, Director of R&D and David Foster, Vice President of Data and Informatics at Metabolon (NC, USA) about the latest developments in microbiome studies, including big data analysis, LCMS, alpha diversity and at-home fecal sample collection.
BioTechniques: Talking Techniues | Greg Michelotti on metabolomics, precision medicine and frailty biomarkers
2 August 2019

BioTechniques: Talking Techniues | Greg Michelotti on metabolomics, precision medicine and frailty biomarkers

BioTechniques Digital Editors Abigail Sawyer and Tristan Free talk to Greg Michelotti of Metabolon (NC, USA) about metabolomics, its potential applications in precision medicine and the new $4 million research collaboration with the Canadian Longitudinal Study of Aging (CLSA) and other Canadian research groups to identify biomarkers for frailty.
WRAL TechWire: Morrisville-based Metabolon mines data for causes of frailty in the elderly
31 July 2019

WRAL TechWire: Morrisville-based Metabolon mines data for causes of frailty in the elderly

Metabolon, a Morrisville-based precision health company specializing in a technology called metabolomics, is teaming with three Canadian research groups to discover humans’ frailty biomarkers, determine the severity of frailty and what can be done to help avoid the condition.
North Carolina Biotechnology Center: Metabolon Mines Data for Causes of Frailty in the Elderly
29 July 2019

North Carolina Biotechnology Center: Metabolon Mines Data for Causes of Frailty in the Elderly

Some people age with relative ease, while others become medically frail. They lose strength, fatigue more easily, or their health, social and psychological challenges accumulate, and they must depend on others for assistance with activities of daily living.
Health Research Innovation Portal: Partnership created to uncover reasons for frailty in aging populations
10 July 2019

Health Research Innovation Portal: Partnership created to uncover reasons for frailty in aging populations

Three national research groups and a leading biotechnology company are teaming together to discover the frailty biomarkers that may shed light on why some people become frail, determine the severity of frailty and what can be done to help avoid the condition.
Biospace: Partnership created to uncover reasons for frailty in aging populations
10 July 2019

Biospace: Partnership created to uncover reasons for frailty in aging populations

To date there has been little consensus on the biological mechanisms underpinning frailty. Analysis of the CLSA samples will allow researchers to identify metabolites that will help to improve not only early prediction of frailty, but also lead to further research on treatments addressing specific aspects of frailty.

Enlighten your research,
accelerate your discovery.

Demo Our Data
or Talk With an Expert

Metabolomics

  • About Metabolomics
  • Our Process
  • Technology & Knowledgebase
  • Setting the Standard: The 4Cs
  • Insights & Discoveries

Solutions

  • Products & Services
  • By Research & Development Phase
  • By Therapeutic Area
  • By Sector

Insights

  • Our Latest Insights
  • Blog
  • News & Events

Resources

  • Resource Library
  • Client Stories
  • COVID-19

Company

  • About Us
  • Working With Us (FAQ)
  • Leadership
  • Careers
  • Strategic Partnering
  • News & Events
  • Contact Us
Metabolon - Logo - Enlightening Life

Metabolon provides actionable biological insights to answer the toughest questions in life sciences research and drug development.

© 2021 Metabolon, Inc. All rights reserved. Privacy & Terms

in
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.